<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An examination was made of the behaviour of platelet function after a single i.v. injection of 150 mg Buflomedil in 8 non-diabetic vasculopathic patients </plain></SENT>
<SENT sid="1" pm="."><plain>The drug was followed by a significant reduction of the platelet aggregability induced by <z:chebi fb="13" ids="16761">ADP</z:chebi> and <z:chebi fb="47" ids="28918,33568">adrenaline</z:chebi>, but not by collagen, and did not alter the percentage of reversible circulating platelet aggregates </plain></SENT>
<SENT sid="2" pm="."><plain>Its action was limited in time, since no activity was observed after 24 hr </plain></SENT>
<SENT sid="3" pm="."><plain>The drug was also clinically evaluated in 30 patients aged over 80 yr with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0241832" disease_type="Disease or Syndrome" abbrv="">cerebrovascular insufficiency</z:e>, following treatment with 100 mg/day i.v. for 20 days, and then 450 mg/day per os for 80 days </plain></SENT>
<SENT sid="4" pm="."><plain>Significant improvements were noted in <z:hpo ids='HP_0002321'>vertigo</z:hpo>, <z:hpo ids='HP_0000360'>tinnitus</z:hpo>, lapses of memory, and the ability to remember numbers </plain></SENT>
<SENT sid="5" pm="."><plain>The results were less impressive with regard to <z:hpo ids='HP_0100785'>insomnia</z:hpo>, <z:hpo ids='HP_0002076'>migraine</z:hpo>, and asthenia </plain></SENT>
</text></document>